Cargando…

Effects of preventive interventions on neuroimaging biomarkers in subjects at-risk to develop Alzheimer's disease: A systematic review

Alzheimer's Disease (AD) is a multifactorial and complex neurodegenerative disorder. Some modifiable risk factors have been associated with an increased risk of appearance of the disease and/or cognitive decline. Preventive clinical trials aiming at reducing one or combined risk factors have be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perus, Lisa, Busto, Germain U., Mangin, Jean-François, Le Bars, Emmanuelle, Gabelle, Audrey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730537/ https://www.ncbi.nlm.nih.gov/pubmed/36506466 http://dx.doi.org/10.3389/fnagi.2022.1014559

Ejemplares similares

Impact of multidomain preventive strategies on functional brain connectivity in older adults with cognitive complaint: Subset from the Montpellier center of the ancillary MAPT-MRI study
por: Perus, Lisa, et al.
Publicado: (2023)

Editorial: Neuroimaging Biomarkers and Cognition in Alzheimer's Disease Spectrum
por: Chen, Jiu, et al.
Publicado: (2022)

Depressive Symptoms Have Distinct Relationships With Neuroimaging Biomarkers Across the Alzheimer’s Clinical Continuum
por: Moulinet, Inès, et al.
Publicado: (2022)

An interpretable Alzheimer’s disease oligogenic risk score informed by neuroimaging biomarkers improves risk prediction and stratification
por: Suh, Erica H., et al.
Publicado: (2023)

X chromosome-wide association study of quantitative biomarkers from the Alzheimer’s Disease Neuroimaging Initiative study
por: Wang, Kai-Wen, et al.
Publicado: (2023)

Should artificial intelligence be used in conjunction with Neuroimaging in the diagnosis of Alzheimer’s disease?
por: Mirkin, Sophia, et al.
Publicado: (2023)

An integrated neuroimaging-omics approach for the gut-brain communication pathways in Alzheimer’s disease
por: Sheng, Can, et al.
Publicado: (2023)

The role of APOE4 in Alzheimer’s disease: strategies for future therapeutic interventions
por: Hunsberger, Holly C., et al.
Publicado: (2019)

Early-stage differentiation between Alzheimer’s disease and frontotemporal lobe degeneration: Clinical, neuropsychology, and neuroimaging features
por: Li, Pan, et al.
Publicado: (2022)

Editorial: Measurable brain and cognitive reserve: The implication of neuroimaging biomarkers in the normal aging process
por: Huang, Chu-Chung, et al.
Publicado: (2022)

Editorial: Biomarkers from multi-tracer and multi-modal neuroimaging in age-related neurodegenerative diseases
por: Nie, Binbin
Publicado: (2022)

Loop diuretics association with Alzheimer’s disease risk
por: Graber-Naidich, Anna, et al.
Publicado: (2023)

Comparison of ultrasensitive and mass spectrometry quantification of blood-based amyloid biomarkers for Alzheimer’s disease diagnosis in a memory clinic cohort
por: Hirtz, Christophe, et al.
Publicado: (2023)

Effects of a lifestyle intervention on the biomarkers of oxidative stress in non-communicable diseases: A systematic review
por: Husain, Sarah, et al.
Publicado: (2023)

Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts
por: Cao, Lei, et al.
Publicado: (2016)

Highlighting the value of Alzheimer’s disease-focused registries: lessons learned from cancer surveillance
por: Miller, Margaret C., et al.
Publicado: (2023)

Neural correlates of subjective cognitive decline in adults at high risk for Alzheimer’s disease
por: Ben-Ami, Liat, et al.
Publicado: (2023)

An update on mobile applications collecting data among subjects with or at risk of Alzheimer's disease
por: Piendel, Lydia, et al.
Publicado: (2023)

Salivary inflammatory biomarkers are predictive of mild cognitive impairment and Alzheimer’s disease in a feasibility study
por: McNicholas, Kym, et al.
Publicado: (2022)

The preservation of right cingulum fibers in subjective cognitive decline of preclinical phase of Alzheimer’s disease
por: Sun, Yu, et al.
Publicado: (2023)

Genome-Wide Association Study of Alzheimer’s Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer’s Disease Multimodal Biomarker Discovery Dataset
por: Homann, Jan, et al.
Publicado: (2022)

G-quadruplexes and associated proteins in aging and Alzheimer’s disease
por: Vijay Kumar, M. J., et al.
Publicado: (2023)

Emerging Electroencephalographic Biomarkers to Improve Preclinical to Clinical Translation in Alzheimer’s Disease
por: Cope, Zackary A., et al.
Publicado: (2022)

Associations of Polygenic Risk Score for Late-Onset Alzheimer's Disease With Biomarkers
por: Li, Qiaojun, et al.
Publicado: (2022)

Exploration of novel biomarkers in Alzheimer’s disease based on four diagnostic models
por: Zou, Cuihua, et al.
Publicado: (2023)

Effect of renal function on the diagnostic performance of plasma biomarkers for Alzheimer’s disease
por: Zhang, Bin, et al.
Publicado: (2023)

Acupuncture on mild cognitive impairment: A systematic review of neuroimaging studies
por: Yin, Zihan, et al.
Publicado: (2023)

Editorial: Molecular mechanisms of Alzheimer’s disease: From top to bottom
por: Mello-Carpes, Pâmela B., et al.
Publicado: (2022)

Neuropathology of Aging in Cats and its Similarities to Human Alzheimer’s Disease
por: Sordo, Lorena, et al.
Publicado: (2021)

Friend or Foe? Defining the Role of Glutamate in Aging and Alzheimer’s Disease
por: Cox, MaKayla F., et al.
Publicado: (2022)

Amyloid-β in Alzheimer’s disease – front and centre after all?
por: Weglinski, Caroline, et al.
Publicado: (2023)

Impact prediction of translocation of the mitochondrial outer membrane 70 as biomarker in Alzheimer's disease
por: Cao, Xi, et al.
Publicado: (2022)

Urinary protein biomarkers based on LC–MS/MS analysis to discriminate vascular dementia from Alzheimer’s disease in Han Chinese population
por: Chen, Ruijuan, et al.
Publicado: (2023)

Abnormal regional homogeneity in right caudate as a potential neuroimaging biomarker for mild cognitive impairment: A resting-state fMRI study and support vector machine analysis
por: Gao, Yujun, et al.
Publicado: (2022)

Sex Differences in Large Artery Stiffness: Implications for Cerebrovascular Dysfunction and Alzheimer’s Disease
por: Kehmeier, Mackenzie N., et al.
Publicado: (2021)

Iron chelators as a therapeutic option for Alzheimer’s disease—A mini-review
por: Schreiner, Oliver Daniel, et al.
Publicado: (2023)

Neuroimaging Biomarkers for Alzheimer’s Disease
por: Márquez, Freddie, et al.
Publicado: (2019)

Exploring the combined effects of sleep apnea and APOE-e4 on biomarkers of Alzheimer’s disease
por: Turner, Arlener D., et al.
Publicado: (2023)

Demonstrating a Technology-Mediated Intervention to Support Medication Adherence in Community-Dwelling Older Adults in Primary Care: A Feasibility Study
por: Siu, Henry Yu-Hin, et al.
Publicado: (2019)

Multimodality neuroimaging in vascular mild cognitive impairment: A narrative review of current evidence
por: Liu, Qiuping, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7dmbd2sgsjm225dah3bt8ib47s